The global Biosurgery Market, valued at USD 15.0 million in 2022, is projected to reach USD 27.8 million by 2032, with a compound annual growth rate (CAGR) of 7.1% during the forecast period. The growth of the market is primarily driven by factors such as the increasing prevalence of chronic diseases, trauma cases, and accidents, as well as the growing demand for surgical treatments.
Biosurgery, an innovative technology aimed at minimizing blood loss and improving tissue repair, is widely used in various surgical procedures involving the circulatory system, thorax, orthopedics, and neurological systems.
The rising number of surgeries conducted worldwide is a significant driver of revenue growth in the biosurgery market. Additionally, the aging population has led to an increased demand for surgical procedures to treat chronic illnesses like cancer and diabetes, further fueling the need for biosurgery products. The market also benefits from the growing number of sports-related injuries requiring biosurgery interventions.
Get a free sample PDF of the report, visit @ https://www.reportsanddata.com/download-free-sample/4612
The introduction of novel and innovative biosurgery products is another key driver of market growth. Manufacturers invest heavily in research and development to develop cutting-edge biosurgery solutions that enhance surgical outcomes and expedite recovery. For instance, in July 2021, Baxter International Inc. introduced Hemostat Gauze, a new biosurgical device designed to prevent bleeding during surgical procedures.
Key players in the Biosurgery Market:
- Baxter International Inc.
- B. Braun Melsungen AG
- Johnson Johnson Services, Inc.
- Stryker Corporation
- Medtronic plc
- C.R. Bard, Inc.
- Integra LifeSciences Holdings Corporation
- CryoLife, Inc.
- Sanofi SA
- Hemostasis, LLC
Increasing awareness among consumers and healthcare professionals about the advantages of biosurgery products is boosting market revenue. Healthcare professionals are increasingly adopting biosurgery products due to their superior benefits compared to conventional surgical techniques, such as reduced blood loss, faster healing times, and lower infection risks.
However, the high cost of biosurgery products and the absence of reimbursement policies in developing countries pose challenges to market growth. Additionally, poor healthcare infrastructure and a lack of trained medical professionals in underdeveloped nations can hinder revenue growth.
According to the International Society of Biosurgeons, the global sales of medical devices used in surgery are estimated to reach USD 90 billion by 2021. The United States holds the largest market share for biosurgery products, followed by Europe, Asia Pacific, and other regions. The Asia Pacific market is expected to exhibit the fastest revenue CAGR during the forecast period, driven by increasing demand from hospitals and healthcare facilities in countries like India, China, and Japan.
To know more about the latest insights of the report, visit @ https://www.reportsanddata.com/request-latest-insight/4612
Government regulations play a crucial role in ensuring the safety and efficacy of biosurgery products. For example, the U.S. Food and Drug Administration (FDA) regulates all medical devices used in biosurgery procedures, requiring them to meet strict safety standards before they can be sold or distributed in the U.S. Similar regulations are enforced by the European Commission, the Japanese Ministry of Health, Labor and Welfare, and the Chinese Food and Drug Administration.
The global biosurgery market is segmented based on product type and application. The product types include hemostatic agents, sealants, adhesion barriers, soft tissue attachments, and bone graft substitutes. Among these, hemostatic agents hold the largest revenue share in 2022, driven by their efficiency in controlling bleeding during surgical procedures. The sealants segment is expected to grow at the fastest rate during the forecast period, supported by their increasing use in various surgical procedures such as orthopedic, cardiovascular, and neurosurgery. The adhesion barriers segment is also anticipated to contribute significantly to market revenue due to their ability to prevent adhesions between tissues after surgical treatments.
In terms of application, the market is segmented into orthopedic surgery, general surgery, neurological surgery, cardiovascular surgery, reconstructive surgery, and others. Orthopedic surgery accounted for the largest revenue share in 2022, attributed to the rising incidence of bone ailments and sports-related injuries.
Request customization of the report @ https://www.reportsanddata.com/request-customization-form/4612
Thank you for reading our report. Please connect with us to know more about the report and its customization feature. Our team will ensure the report is well suited to meet your requirements.
Browse for more reports:
https://navajopost.org/suture-market-major-companies-growth-strategies-and-new-trends-by-2028/
https://navajopost.org/stethoscope-market-development-strategies-swot-analysis-and-trends-till-2028/
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact:
John W, Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs
